Jakob, Jens

[["dc.bibliographiccitation.firstpage","810"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","International Journal of Radiation Oncology, Biology, Physics"],["dc.bibliographiccitation.lastpage","816"],["dc.bibliographiccitation.volume","75"],["dc.contributor.author","Jakob, Jens"],["dc.contributor.author","Wenz, Frederik"],["dc.contributor.author","Dinter, Dietmar J."],["dc.contributor.author","Ströbel, Philipp"],["dc.contributor.author","Hohenberger, Peter"],["dc.date.accessioned","2020-11-23T13:34:19Z"],["dc.date.available","2020-11-23T13:34:19Z"],["dc.date.issued","2009-11-01"],["dc.description.abstract","To evaluate the toxicity and efficacy of preoperative intensity-modulated radiotherapy (IMRT) combined with temozolomide to improve local tumor control in soft-tissue sarcoma (STS)."],["dc.identifier.doi","10.1016/j.ijrobp.2008.11.032"],["dc.identifier.pmid","19307066"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/69018"],["dc.language.iso","en"],["dc.relation.eissn","1879-355X"],["dc.relation.issn","0360-3016"],["dc.title","Preoperative intensity-modulated radiotherapy combined with temozolomide for locally advanced soft-tissue sarcoma"],["dc.type","journal_article"],["dc.type.internalPublication","no"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","10554"],["dc.bibliographiccitation.issue","15, Suppl."],["dc.bibliographiccitation.journal","Journal of Clinical Oncology"],["dc.bibliographiccitation.volume","32"],["dc.contributor.author","Hohenberger, Peter"],["dc.contributor.author","Menge, Franka"],["dc.contributor.author","Jakob, Jens"],["dc.contributor.author","Ronellenfitsch, Ulrich"],["dc.contributor.author","Mathew, Monika"],["dc.contributor.author","Marx, Alexander"],["dc.contributor.author","Kasper, Bernd"],["dc.contributor.author","Reichardt, Peter"],["dc.contributor.author","Wardelmann, Eva"],["dc.date.accessioned","2020-11-23T13:33:34Z"],["dc.date.available","2020-11-23T13:33:34Z"],["dc.date.issued","2014"],["dc.identifier.doi","10.1200/jco.2014.32.15_suppl.10554"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/69010"],["dc.relation.issn","0732-183X"],["dc.relation.issn","1527-7755"],["dc.title","Metastatic pattern of late metastases of gastrointestinal stromal tumors and the contribution radiation therapy for disease control"],["dc.type","journal_article"],["dc.type.internalPublication","no"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","S689"],["dc.bibliographiccitation.journal","European Journal of Cancer"],["dc.bibliographiccitation.lastpage","S690"],["dc.bibliographiccitation.volume","51"],["dc.contributor.author","Raut, C."],["dc.contributor.author","Miceli, R."],["dc.contributor.author","Strauss, D."],["dc.contributor.author","Swallow, C."],["dc.contributor.author","Hohenberger, P."],["dc.contributor.author","Van Coevorden, F."],["dc.contributor.author","Rutkowski, P."],["dc.contributor.author","Fiore, M."],["dc.contributor.author","Callegaro, D."],["dc.contributor.author","Casali, P."],["dc.contributor.author","Haas, R."],["dc.contributor.author","Hayes, A."],["dc.contributor.author","Honore, C."],["dc.contributor.author","Cannell, A."],["dc.contributor.author","Jakob, J."],["dc.contributor.author","Szacht, M."],["dc.contributor.author","Fairweather, M."],["dc.contributor.author","Pollock, R."],["dc.contributor.author","Bonvalot, S."],["dc.contributor.author","Gronchi, A."],["dc.date.accessioned","2020-11-23T13:33:03Z"],["dc.date.available","2020-11-23T13:33:03Z"],["dc.date.issued","2015"],["dc.identifier.doi","10.1016/S0959-8049(16)31879-2"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/69005"],["dc.relation.issn","0959-8049"],["dc.title","3404 External validation of a nomogram predicting disease-free (DFS) and overall survival (OS) in patients (pts) with primary retroperitoneal sarcoma (pRPS)"],["dc.type","journal_article"],["dc.type.internalPublication","no"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","10560"],["dc.bibliographiccitation.issue","15, Suppl."],["dc.bibliographiccitation.journal","Journal of Clinical Oncology"],["dc.bibliographiccitation.volume","26"],["dc.contributor.author","Mussi, C."],["dc.contributor.author","Jakob, J."],["dc.contributor.author","Wardelmann, E."],["dc.contributor.author","Reichardt, P."],["dc.contributor.author","Casali, P. G."],["dc.contributor.author","Fiore, M."],["dc.contributor.author","Collini, P."],["dc.contributor.author","Gronchi, A."],["dc.contributor.author","Hohenberger, P."],["dc.date.accessioned","2020-11-23T13:34:30Z"],["dc.date.available","2020-11-23T13:34:30Z"],["dc.date.issued","2008"],["dc.identifier.doi","10.1200/jco.2008.26.15_suppl.10560"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/69021"],["dc.relation.issn","0732-183X"],["dc.relation.issn","1527-7755"],["dc.title","Gastrointestinal stromal tumor of the rectum and rectovaginal space: A retrospective review"],["dc.type","journal_article"],["dc.type.internalPublication","no"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","343"],["dc.bibliographiccitation.issue","4"],["dc.bibliographiccitation.journal","Der Onkologe"],["dc.bibliographiccitation.lastpage","351"],["dc.bibliographiccitation.volume","27"],["dc.contributor.author","Jo, P."],["dc.contributor.author","Jakob, Jens"],["dc.date.accessioned","2021-04-14T08:29:10Z"],["dc.date.available","2021-04-14T08:29:10Z"],["dc.date.issued","2021"],["dc.identifier.doi","10.1007/s00761-021-00903-0"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/82822"],["dc.language.iso","de"],["dc.notes.intern","DOI Import GROB-399"],["dc.relation.eissn","1433-0415"],["dc.relation.issn","0947-8965"],["dc.title","Toxizität und Effektivität lokoregionaler Chemotherapien"],["dc.title.translated","Toxicity and effectiveness of locoregional chemotherapy"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","959"],["dc.bibliographiccitation.issue","5"],["dc.bibliographiccitation.journal","Annals of Surgery"],["dc.bibliographiccitation.lastpage","964"],["dc.bibliographiccitation.volume","267"],["dc.contributor.author","MacNeill, Andrea J."],["dc.contributor.author","Gronchi, Alessandro"],["dc.contributor.author","Miceli, Rosalba"],["dc.contributor.author","Bonvalot, Sylvie"],["dc.contributor.author","Swallow, Carol J."],["dc.contributor.author","Hohenberger, Peter"],["dc.contributor.author","Van Coevorden, Frits"],["dc.contributor.author","Rutkowski, Piotr"],["dc.contributor.author","Callegaro, Dario"],["dc.contributor.author","Hayes, Andrew J."],["dc.contributor.author","Honoré, Charles"],["dc.contributor.author","Fairweather, Mark"],["dc.contributor.author","Cannell, Amanda"],["dc.contributor.author","Jakob, Jens"],["dc.contributor.author","Haas, Rick L."],["dc.contributor.author","Szacht, Milena"],["dc.contributor.author","Fiore, Marco"],["dc.contributor.author","Casali, Paolo G."],["dc.contributor.author","Pollock, Raphael E."],["dc.contributor.author","Barretta, Francesco"],["dc.contributor.author","Raut, Chandrajit P."],["dc.contributor.author","Strauss, Dirk C."],["dc.date.accessioned","2020-11-23T13:32:06Z"],["dc.date.available","2020-11-23T13:32:06Z"],["dc.date.issued","2018"],["dc.description.abstract","To investigate the safety of radical resection for retroperitoneal sarcoma (RPS)."],["dc.identifier.doi","10.1097/SLA.0000000000002250"],["dc.identifier.pmid","28394870"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/68992"],["dc.language.iso","en"],["dc.relation.eissn","1528-1140"],["dc.relation.issn","0003-4932"],["dc.title","Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working Group"],["dc.type","journal_article"],["dc.type.internalPublication","no"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","431"],["dc.bibliographiccitation.issue","4"],["dc.bibliographiccitation.journal","Der Pathologe"],["dc.bibliographiccitation.lastpage","435"],["dc.bibliographiccitation.volume","40"],["dc.contributor.author","Jakob, J."],["dc.contributor.author","Hohenberger, P."],["dc.date.accessioned","2020-11-23T13:31:12Z"],["dc.date.available","2020-11-23T13:31:12Z"],["dc.date.issued","2019-07"],["dc.description.abstract","Soft-tissue sarcomas are rare malignant tumors. Surgery remains the most important treatment modality. Neoadjuvant and/or adjuvant chemo- and radiotherapy may be administered to improve the local and systemic outcome. Advances in oncological and reconstructive surgery, combined with the use of multimodal therapies, have made mutilating surgery rare events in extremity sarcomas. In retroperitoneal sarcomas, local recurrences are life-threatening events and multivisceral resection has become the standard surgical procedure. The subjects of this review are diagnostics, multimodal therapy, and resection strategy from a surgical point of view."],["dc.identifier.doi","10.1007/s00292-019-0631-2"],["dc.identifier.pmid","31240451"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/68982"],["dc.language.iso","other"],["dc.relation.eissn","1432-1963"],["dc.relation.issn","0172-8113"],["dc.title","Prinzipien der Sarkomchirurgie"],["dc.title.alternative","Principles of sarcoma surgery"],["dc.type","journal_article"],["dc.type.internalPublication","no"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","301"],["dc.bibliographiccitation.issue","6"],["dc.bibliographiccitation.journal","Oncology Research and Treatment"],["dc.bibliographiccitation.lastpage","312"],["dc.bibliographiccitation.volume","44"],["dc.contributor.author","Eichler, Martin"],["dc.contributor.author","Andreou, Dimosthenis"],["dc.contributor.author","Golcher, Henriette"],["dc.contributor.author","Hentschel, Leopold"],["dc.contributor.author","Richter, Stephan"],["dc.contributor.author","Hohenberger, Peter"],["dc.contributor.author","Kasper, Bernd"],["dc.contributor.author","Pink, Daniel"],["dc.contributor.author","Jakob, Jens"],["dc.contributor.author","Schuler, Markus K."],["dc.date.accessioned","2021-06-01T09:42:10Z"],["dc.date.available","2021-06-01T09:42:10Z"],["dc.date.issued","2021"],["dc.description.abstract","Background: Data on institutional structures of sarcoma care in Germany are scarce. The utilization of an interdisciplinary tumor board (IDTB) is an essential part of modern cancer care. We investigated to which extent and when IDTB are used in sarcoma care. We hypothesized that IDTB before treatment initiation were used more often at certified cancer centers and at high-volume centers and that IDTB utilization increased over time. Methods: From 2017 to 2020 we conducted a prospective cohort study, undertaking major efforts to include the whole spectrum of sarcoma treatment facilities. To analyze potential predictors of IDTB utilization, we calculated multivariable logistic regressions. Results: Patients and survivors (n = 1,309) from 39 study centers (22 tertiary referral hospitals, 9 other hospitals, and 8 office-based practices) participated; 88.3% of the patients were discussed at some stage of their disease in an IDTB (56.1% before treatment, 78% after therapy, and 85.9% in metastatic disease). Hypotheses were confirmed regarding the utilization of IDTB in certified cancer centers (vs. all others: OR = 5.39; 95% CI 3.28–8.85) and the time of diagnosis (2018/2019 vs. until 2013: OR = 4.95; 95% CI 2.67–9.21). Conclusion:Our study adds to the evidence regarding the institutional structures of sarcoma care in Germany. Utilization of a tumor board before therapy seems to be in an implementation process that is making progress but is far from complete. Certification is a possible tool to accelerate this development."],["dc.identifier.doi","10.1159/000516262"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/85163"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-425"],["dc.relation.eissn","2296-5262"],["dc.relation.issn","2296-5270"],["dc.title","Utilization of Interdisciplinary Tumor Boards for Sarcoma Care in Germany: Results from the PROSa Study"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","e009558"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","BMJ Open"],["dc.bibliographiccitation.volume","6"],["dc.contributor.author","Ronellenfitsch, Ulrich"],["dc.contributor.author","Dimitrakopoulou-Strauss, Antonia"],["dc.contributor.author","Jakob, Jens"],["dc.contributor.author","Kasper, Bernd"],["dc.contributor.author","Nowak, Kai"],["dc.contributor.author","Pilz, Lothar R."],["dc.contributor.author","Attenberger, Ulrike"],["dc.contributor.author","Gaiser, Timo"],["dc.contributor.author","Egerer, Gerlinde"],["dc.contributor.author","Fröhling, Stefan"],["dc.contributor.author","Derigs, Hans-Günter"],["dc.contributor.author","Schwarzbach, Matthias"],["dc.contributor.author","Hohenberger, Peter"],["dc.date.accessioned","2020-11-23T13:32:57Z"],["dc.date.available","2020-11-23T13:32:57Z"],["dc.date.issued","2016-01-06"],["dc.description.abstract","For resectable soft tissue sarcoma (STS), radical surgery, usually combined with radiotherapy, is the mainstay of treatment and the only potentially curative modality. Since surgery is often complicated by large tumour size and extensive tumour vasculature, preoperative treatment strategies with the aim of devitalising the tumour are being explored. One option is treatment with antiangiogenic drugs. The multikinase inhibitor pazopanib, which possesses pronounced antiangiogenic effects, has shown activity in metastatic and unresectable STS, but has so far not been tested in the preoperative setting."],["dc.identifier.doi","10.1136/bmjopen-2015-009558"],["dc.identifier.pmid","26739732"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/69004"],["dc.language.iso","en"],["dc.relation.issn","2044-6055"],["dc.title","Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS)"],["dc.type","journal_article"],["dc.type.internalPublication","no"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","50"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Der Chirurg"],["dc.bibliographiccitation.lastpage","55"],["dc.bibliographiccitation.volume","89"],["dc.contributor.author","Jakob, J."],["dc.contributor.author","Gerres, A."],["dc.contributor.author","Ronellenfitsch, U."],["dc.contributor.author","Pilz, L."],["dc.contributor.author","Wartenberg, M."],["dc.contributor.author","Kasper, B."],["dc.contributor.author","Raab, H.-R."],["dc.contributor.author","Hohenberger, P."],["dc.date.accessioned","2020-11-23T13:32:32Z"],["dc.date.available","2020-11-23T13:32:32Z"],["dc.date.issued","2018"],["dc.description.abstract","Retroperitoneal sarcomas (RPSs) are rare cancers with some variability in clinical and histopathological presentation. In Germany, general treatment strategies of retroperitoneal sarcoma are unknown since centralized registries do not exist. The objective of this survey was to access the medical care of RPS patients in Germany."],["dc.identifier.doi","10.1007/s00104-017-0504-2"],["dc.identifier.pmid","28905080"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/68998"],["dc.language.iso","other"],["dc.relation.eissn","1433-0385"],["dc.relation.issn","0009-4722"],["dc.title","Behandlung retroperitonealer Sarkome in Deutschland"],["dc.title.alternative","Treatment of retroperitoneal sarcoma in Germany. Results of a survey of the German Society of General and Visceral Surgery, the German Interdisciplinary Sarcoma Study Group and the advocacy group Das Lebenshaus"],["dc.title.subtitle","Eine Umfrage der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie, der Deutschen Interdisziplinären Studiengruppe Sarkome und der Patientenorganisation Das Lebenshaus"],["dc.type","journal_article"],["dc.type.internalPublication","no"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]